Suppr超能文献

住院和非住院炎症性肠病患者合并症的相关因素:一项单中心初步研究。

Factors associated with comorbidity in hospitalized and non-hospitalized inflammatory bowel disease patients: A single-center, preliminary study.

作者信息

Lenti Marco Vincenzo, Brera Alice Silvia, Broglio Giacomo, Bertolino Giampiera, Di Sabatino Antonio, Klersy Catherine, Corazza Gino Roberto

机构信息

Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.

First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

出版信息

J Multimorb Comorb. 2025 Aug 20;15:26335565251365040. doi: 10.1177/26335565251365040. eCollection 2025 Jan-Dec.

Abstract

BACKGROUND

Inflammatory bowel disease (IBD) may be burdened by other comorbid conditions. We herein sought to assess comorbidity in hospitalized and non-hospitalized IBD patients.

METHODS

This was part of the San MAtteo Complexity (SMAC) study (2017-2019). Data of hospitalized IBD patients were compared to gender- and age-matched IBD outpatients in a 2:1 fashion. The association of comorbidity in relation to hospitalization and clinical and socioeconomic factors was assessed.

RESULTS

We included 104 patients, 27 hospitalized (median age 49 years, IQR 32-70) and 77 outpatients (median age 54 years, IQR 37-68). Comorbidity was reported in 63/104 patients (60.6%), of whom 45 (58.5%) non-hospitalized and 18 (66.6%) hospitalized. Patients with comorbidity were older (median 60 years, IQR 44-61 vs median 40 years, IQR 28-50 vs; p<0.001), had a higher Cumulative Illness Rating Scale severity index (median 1.85, IQR 1.5-2.5 vs median 1.31, IQR 1.2-2.5; p=0.002), were more commonly female (37, 60.7% vs 14, 35.0%; p=0.01), frailer (14, 22.2% vs 1, 2.4%; p=0.004), and had a lower educational level (13, 20.6% vs 2, 4.9%; p=0.04). In a bivariable analysis, factors associated to comorbidity were age >65 years (OR 5.30, 95% CI 1.81-15.55; p=0.002), female sex (OR 2.92, 95% CI 1-27-6.71; p=0.012), income <1000€ (OR 3.04, 95% CI 1.09-8.44; p=0.033), schooling <8 years (OR 5.09, 95% CI 1.08-23.96; p=0.039), frailty (OR 12.56, 95% CI 1.48-106.45; p=0.020), and polypharmacy (OR 10.41, 95% CI 1.85-59.38; p=0.008).

CONCLUSION

A high prevalence of comorbidity was found in IBD, possibly related to low socioeconomic status and poor educational level.

摘要

背景

炎症性肠病(IBD)可能伴有其他合并症。我们在此旨在评估住院和非住院IBD患者的合并症情况。

方法

这是圣马泰奥复杂性(SMAC)研究(2017 - 2019年)的一部分。将住院IBD患者的数据与按2:1比例匹配的性别和年龄的IBD门诊患者进行比较。评估合并症与住院情况以及临床和社会经济因素的关联。

结果

我们纳入了104例患者,27例住院患者(中位年龄49岁,四分位间距32 - 70岁)和77例门诊患者(中位年龄54岁,四分位间距37 - 68岁)。104例患者中有63例(60.6%)报告有合并症,其中45例(58.5%)非住院患者和18例(66.6%)住院患者。有合并症的患者年龄更大(中位年龄60岁,四分位间距44 - 61岁,而无合并症患者中位年龄40岁,四分位间距28 - 50岁;p<0.001),累积疾病评定量表严重程度指数更高(中位值1.85,四分位间距1.5 - 2.5,而无合并症患者中位值1.31,四分位间距1.2 - 2.5;p = 0.002),女性更常见(37例,60.7%对14例,35.0%;p = 0.01),身体更虚弱(14例,22.2%对1例,2.4%;p = 0.004),教育水平更低(13例,20.6%对2例,4.9%;p = 0.04)。在双变量分析中,与合并症相关的因素有年龄>65岁(比值比5.30,95%置信区间1.81 - 15.55;p = 0.002)、女性(比值比2.92,95%置信区间1.27 - 6.71;p = 0.012)、收入<1000€(比值比3.04,95%置信区间1.09 - 8.44;p = 0.033)、受教育年限<8年(比值比5.09,95%置信区间1.08 - 23.96;p = 0.039)、身体虚弱(比值比12.56,95%置信区间1.48 - 106.45;p = 0.020)和多种药物治疗(比值比10.41,95%置信区间1.85 - 59.38;p = 0.008)。

结论

IBD患者中合并症的患病率较高,可能与社会经济地位低和教育水平差有关。

相似文献

1
Factors associated with comorbidity in hospitalized and non-hospitalized inflammatory bowel disease patients: A single-center, preliminary study.
J Multimorb Comorb. 2025 Aug 20;15:26335565251365040. doi: 10.1177/26335565251365040. eCollection 2025 Jan-Dec.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.
Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6.
4
Patient education interventions for the management of inflammatory bowel disease.
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
5
Risk of malnutrition increases in the year prior to surgery among patients with inflammatory bowel disease.
Therap Adv Gastroenterol. 2025 Aug 19;18:17562848251365036. doi: 10.1177/17562848251365036. eCollection 2025.
7
Psychological interventions for treatment of inflammatory bowel disease.
Cochrane Database Syst Rev. 2025 Apr 17;4(4):CD006913. doi: 10.1002/14651858.CD006913.pub3.
8
Strategies for detecting colon cancer in patients with inflammatory bowel disease.
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD000279. doi: 10.1002/14651858.CD000279.pub4.
9
Inflammatory bowel disease and pulmonary embolism: a nationwide perspective.
Eur J Gastroenterol Hepatol. 2024 Dec 1;36(12):1410-1418. doi: 10.1097/MEG.0000000000002851. Epub 2024 Sep 12.
10
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Cochrane Database Syst Rev. 2014 Oct 23;2014(10):CD007744. doi: 10.1002/14651858.CD007744.pub2.

本文引用的文献

1
Factors associated to multiple chronic conditions in internal medicine patients.
Eur J Intern Med. 2025 Feb;132:145-147. doi: 10.1016/j.ejim.2024.09.012. Epub 2024 Sep 20.
5
Social determinants of multimorbidity patterns: A systematic review.
Front Public Health. 2023 Mar 27;11:1081518. doi: 10.3389/fpubh.2023.1081518. eCollection 2023.
6
Environmental risk factors for inflammatory bowel disease.
United European Gastroenterol J. 2022 Dec;10(10):1047-1053. doi: 10.1002/ueg2.12319. Epub 2022 Oct 19.
7
Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses.
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2211-2221. doi: 10.1016/j.cgh.2022.06.030. Epub 2022 Jul 19.
8
Resilience is associated with frailty and older age in hospitalised patients.
BMC Geriatr. 2022 Jul 10;22(1):569. doi: 10.1186/s12877-022-03251-9.
9
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2427-2434. doi: 10.1016/j.cgh.2022.03.011. Epub 2022 Mar 17.
10
Aging underlies heterogeneity between comorbidity and multimorbidity frameworks.
Intern Emerg Med. 2022 Jun;17(4):1033-1041. doi: 10.1007/s11739-021-02899-2. Epub 2022 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验